Prognostic Value of CTC collected by ISET®

The prognostic value of CTC collected by ISET® has been demonstrated by multiple independent publications in the context of multiple cancer types, such as Hepato-Cellular Carcinoma (Vona et al. 2004 Hepatology), Non-Small-Cell Lung Cancer (Hofman et al. 2011 Int J Cancer, Hofman et al. 2011 Clin Cancer Res, Chinen et al. 2013 J Thorac Dis, Pailler et al. 2013 J Clin Oncol, Morrow et al. 2016 Ann Oncol, Pailler et al. 2017 Cancer Res, Kallergi et al. 2018 Ther Adv Med Oncol, Diaz et al. 2018 Appl Cancer Res), Small-Cell Lung Cancer (Williamson et al. 2016 Nat Comm), Uveal Melanoma (Mazzini et al. 2014 Cancers), Colorectal Cancer (Abdallah et al. 2015 Int J Cancer, Buim et al. 2015 Cancer Biol Ther, Abdallah et al. 2016 Int J Cancer, Souza e Silva et al. 2016 Oncotargets Ther, Matikas et al. 2017 Transl Oncol, Messaritakis et al. 2018 Cancer Chemother Pharmacol), Pancreatic Cancer (Poruk et al. 2016 Ann Surg), Cutaneous Melanoma (Long et al. 2016 Cancer Med), Head and Neck Cancer (Fanelli et al. 2017 Head & Neck), Ovarian Cancer (Corassa et al. 2017 Applied Cancer Res) and Soft Tissue Sarcoma (Braun et al. 2018 Cancer Biol Ther). Examples are presented in the images below and on the left.